Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Hipgnosis Songs Fund Limited
  6. Summary
    SONG   GG00BFYT9H72

HIPGNOSIS SONGS FUND LIMITED

(SONG)
  Report
Delayed London Stock Exchange  -  11:35 2022-12-07 am EST
80.00 GBX   -1.23%
10:52aUK earnings, trading statements calendar - next 7 days
AN
12/06UK earnings, trading statements calendar - next 7 days
AN
12/05UK earnings, trading statements calendar - next 7 days
AN
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
12/01/2022 12/02/2022 12/05/2022 12/06/2022 12/07/2022 Date
86.5(c) 83.4(c) 81.7(c) 81(c) 80 Last
2 932 687 2 428 524 1 954 244 1 305 745 3 320 463 Volume
+5.49% -3.58% -2.04% -0.86% -1.23% Change
More quotes
Estimated financial data (e)
Sales 2023 129 M 158 M 158 M
Net income 2023 -34,4 M -42,1 M -42,1 M
Net Debt 2023 541 M 663 M 663 M
P/E ratio 2023 -28,4x
Yield 2023 6,48%
Sales 2024 142 M 173 M 173 M
Net income 2024 -37,2 M -45,5 M -45,5 M
Net Debt 2024 522 M 639 M 639 M
P/E ratio 2024 -26,6x
Yield 2024 6,62%
Capitalization 979 M 1 199 M 1 199 M
EV / Sales 2023 11,8x
EV / Sales 2024 10,6x
Nbr of Employees 41
Free-Float 100,0%
More Financials
Company
Hipgnosis Songs Fund Limited is a Guernsey-based investment company. The Company is established to offer investors the exposure to songs and associated musical intellectual property rights. Its principal activities are to invest in a diverse portfolio of song catalogues, to collect income generated across a variety of sources from the ongoing exploitation of copyrights, and to manage the development of the assets.... 
More about the company
Ratings of Hipgnosis Songs Fund Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about HIPGNOSIS SONGS FUND LIMITED
10:52aUK earnings, trading statements calendar - next 7 days
AN
12/06UK earnings, trading statements calendar - next 7 days
AN
12/05UK earnings, trading statements calendar - next 7 days
AN
12/02UK earnings, trading statements calendar - next 7 days
AN
12/01UK earnings, trading statements calendar - next 7 days
AN
10/27UK dividends calendar - next 7 days
AN
10/26UK dividends calendar - next 7 days
AN
10/25UK dividends calendar - next 7 days
AN
10/24UK dividends calendar - next 7 days
AN
10/21UK dividends calendar - next 7 days
AN
10/14Hipgnosis Songs Fund Limited announces an Equity Buyback for repurchase of 14.99% of th..
CI
10/05Hipgnosis Songs Fund Completes Interest Rate Hedging on $540 Million
MT
10/04Music To Their Ears : Hipgnosis Songs Fund calms investor nerves with new debt financing d..
AQ
10/03Hipgnosis Songs Fund Secures $700 Million Revolving Credit Facility
MT
10/03Hipgnosis Songs Fund Limited Announces Debt Refinancing
CI
More news
News in other languages on HIPGNOSIS SONGS FUND LIMITED
10/14Hipgnosis Songs Fund Limited annonce un rachat d'actions pour le rachat de 14,99% du ca..
10/05Le fonds Hipgnosis Songs réalise une couverture de taux d'intérêt sur 540 millions de d..
10/03Le fonds Hipgnosis Songs décroche une facilité de crédit renouvelable de 700 millions d..
09/21Hipgnosis Songs Fund Limited annonce un dividende intérimaire pour la période du 1er av..
08/24Blackstone parmi les soumissionnaires pour le catalogue de Pink Floyd - sources
More news
ETFs positioned on HIPGNOSIS SONGS FUND LIMITEDETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Vanguard FTSE 250 - Acc - GBP0.39%-0.21%UK
HSBC FTSE 250 - GBP0.36%0.52%-UK
Vanguard FTSE 250 - GBP0.36%0.08%UK
Xtrackers FTSE 250 1D - GBP0.36%0.52%UK
More ETFs positioned on HIPGNOSIS SONGS FUND LIMITED
Chart HIPGNOSIS SONGS FUND LIMITED
Duration : Period :
Hipgnosis Songs Fund Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HIPGNOSIS SONGS FUND LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 81,00 GBX
Average target price 130,50 GBX
Spread / Average Target 61,1%
EPS Revisions
Managers and Directors
Merck Mercuriadis Chief Executive Officer
Edward John Cockle President
Christopher Arthur Helm Chief Financial Officer
Andrew Lang Sutch Chairman
Bjorn Olof Lindvall Chief Operating Officer
Sector and Competitors